I actually think that the cleansed website and particularly the added sentence at the top of the main page is very big news! It would not state "CytoDyn is in the process of updating the company's website to provide current information on the status of our development of leronlimab for the indications for which it is being studied", if, as the shorts would have us believe, the company was dying. Anyone with half a brain, which of course excludes the shorts, would conclude that the company is alive and well (albeit annoyingly quiet). There's absolutely no reason for management to proactively state that leronlimab updates are forthcoming if that wasn't actually the case.

So my message to all shorts is as follows: please read the quoted sentence and chew on the fact that leronlimab updates are coming very soon; and chew on this shorts - it means that an epic squeeze is coming. Bon appetite shorts!!